262 related articles for article (PubMed ID: 20880196)
1. Inhaled anticholinergic drugs and risk of acute urinary retention.
Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
[TBL] [Abstract][Full Text] [Related]
2. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.
Stephenson A; Seitz D; Bell CM; Gruneir A; Gershon AS; Austin PC; Fu L; Anderson GM; Rochon PA; Gill SS
Arch Intern Med; 2011 May; 171(10):914-20. PubMed ID: 21606096
[TBL] [Abstract][Full Text] [Related]
3. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
Singh S; Furberg CD
Arch Intern Med; 2011 May; 171(10):920-2. PubMed ID: 21606097
[No Abstract] [Full Text] [Related]
4. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention.
Verhamme KM; Dieleman JP; Van Wijk MA; van der Lei J; Bosch JL; Stricker BH; Sturkenboom MC
Arch Intern Med; 2005 Jul; 165(13):1547-51. PubMed ID: 16009872
[TBL] [Abstract][Full Text] [Related]
6. Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia.
Vande Griend JP; Linnebur SA
Ann Pharmacother; 2012 Sep; 46(9):1245-9. PubMed ID: 22851743
[TBL] [Abstract][Full Text] [Related]
7. Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents.
Alzayer R; Hughes J; Parsons R; Lee YP
Qual Prim Care; 2010; 18(3):189-99. PubMed ID: 20659403
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
9. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Singh S; Loke YK; Enright P; Furberg CD
Postgrad Med J; 2014 Apr; 90(1062):205-7. PubMed ID: 24643260
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia.
Miyazaki H; Suda T; Otsuka A; Nagata M; Ozono S; Hashimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Pulm Pharmacol Ther; 2008 Dec; 21(6):879-83. PubMed ID: 18992357
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
Verhamme KM; Afonso AS; van Noord C; Haag MD; Koudstaal PJ; Brusselle GG; Sturkenboom MC
Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450
[TBL] [Abstract][Full Text] [Related]
12. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Singh S; Loke YK; Enright P; Furberg CD
Thorax; 2013 Jan; 68(1):114-6. PubMed ID: 22764216
[TBL] [Abstract][Full Text] [Related]
13. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
Cole JM; Sheehan AH; Jordan JK
Ann Pharmacother; 2012 Dec; 46(12):1717-21. PubMed ID: 23170031
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of acute urinary retention in the general male population: the triumph project.
Verhamme KM; Dieleman JP; van Wijk MA; Bosch JL; Stricker BH; Sturkenboom MC
Eur Urol; 2005 Apr; 47(4):494-8. PubMed ID: 15774248
[TBL] [Abstract][Full Text] [Related]
15. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.
Wang MT; Tsai CL; Lo YW; Liou JT; Lee WJ; Lai IC
Int J Cardiol; 2012 Jul; 158(2):279-84. PubMed ID: 22386700
[TBL] [Abstract][Full Text] [Related]
16. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
17. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study.
Chen JS; Chang CH; Yang WH; Kao YH
BJU Int; 2012 Dec; 110(11 Pt C):E896-901. PubMed ID: 23035623
[TBL] [Abstract][Full Text] [Related]
18. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic treatment in airways diseases.
Flynn RA; Glynn DA; Kennedy MP
Adv Ther; 2009 Oct; 26(10):908-19. PubMed ID: 19967500
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
